Literature DB >> 32976098

Multifocused Ultrasound Therapy for Controlled Microvascular Permeabilization and Improved Drug Delivery.

Lokesh Basavarajappa, Girdhari Rijal, Kenneth Hoyt.   

Abstract

Focused ultrasound (FUS) exposure of micro-bubble (MB) contrast agents can transiently increase microvascular permeability allowing anticancer drugs to extravasate into a targeted tumor tissue. Either fixed or mechanically steered in space, most studies to date have used a single element focused transducer to deliver the ultrasound (US) energy. The goal of this study was to investigate various multi-FUS strategies implemented on a programmable US scanner (Vantage 256, Verasonics Inc.) equipped with a linear array for image guidance and a 128-element therapy transducer (HIFUPlex-06, Sonic Concepts). The multi-FUS strategies include multi-FUS with sequential excitation (multi-FUS-SE) and multi-FUS with temporal sequential excitation (multi-FUS-TSE) and were compared to single-FUS and sham treatment. This study was performed using athymic mice implanted with breast cancer cells ( N = 20 ). FUS therapy experiments were performed for 10 min after a solution containing MBs (Definity, Lantheus Medical Imaging Inc.) and near-infrared (NIR, surrogate drug) dye were injected via the tail vein. The fluorescent signal was monitored using an in vivo optical imaging system (Pearl Trilogy, LI-COR) to quantify intratumoral dye accumulation at baseline and again at 0.1, 24, and 48 h after receiving US therapy. Animals were then euthanized for ex vivo dye extraction analysis. At 48 h, fluorescent tracer accumulation within the tumor space for the multi-FUS-TSE therapy group animals was found to be 67.3%, 50.3%, and 36.2% higher when compared to sham, single-FUS, and multi-FUS-SE therapy group measures, respectively. Also, dye extraction and fluorescence measurements from excised tumor tissue found increases of 243.2%, 163.1%, and 68.1% for the multi-FUS-TSE group compared to sham, single-FUS, and multi-FUS-SE therapy group measures, respectively. In summary, experimental results revealed that for a multi-FUS sequence, increased microvascular permeability was considerably influenced by both the spatial and temporal aspects of the applied US therapy.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32976098      PMCID: PMC8034541          DOI: 10.1109/TUFFC.2020.3026697

Source DB:  PubMed          Journal:  IEEE Trans Ultrason Ferroelectr Freq Control        ISSN: 0885-3010            Impact factor:   2.725


  41 in total

Review 1.  Bioeffects considerations for diagnostic ultrasound contrast agents.

Authors:  Douglas L Miller; Michalakis A Averkiou; Andrew A Brayman; E Carr Everbach; Christy K Holland; James H Wible; Junru Wu
Journal:  J Ultrasound Med       Date:  2008-04       Impact factor: 2.153

2.  Passive cavitation imaging with ultrasound arrays.

Authors:  Vasant A Salgaonkar; Saurabh Datta; Christy K Holland; T Douglas Mast
Journal:  J Acoust Soc Am       Date:  2009-12       Impact factor: 1.840

3.  A random phased array device for delivery of high intensity focused ultrasound.

Authors:  J W Hand; A Shaw; N Sadhoo; S Rajagopal; R J Dickinson; L R Gavrilov
Journal:  Phys Med Biol       Date:  2009-09-01       Impact factor: 3.609

4.  Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo.

Authors:  Jennifer C Wischhusen; Sayan Mullick Chowdhury; Taehwa Lee; Huaijun Wang; Sunitha Bachawal; Rammohan Devulapally; Rayhaneh Afjei; Uday Kumar Sukumar; Ramasamy Paulmurugan
Journal:  J Control Release       Date:  2020-01-29       Impact factor: 9.776

5.  Microbubble Compositions, Properties and Biomedical Applications.

Authors:  Shashank Sirsi; Mark Borden
Journal:  Bubble Sci Eng Technol       Date:  2009-11

6.  The Long-Term Fate of the Sonoporated Pancreatic Cancer Cells is Uncorrelated With the Degree of Model Molecular Loading.

Authors:  Lizhou Lin; Mouwen Cheng; Rong Wu; Qiusheng Shi; Lianfang Du; Peng Qin
Journal:  Ultrasound Med Biol       Date:  2020-01-11       Impact factor: 2.998

7.  Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study.

Authors:  Spiros Kotopoulis; Georg Dimcevski; Odd Helge Gilja; Dag Hoem; Michiel Postema
Journal:  Med Phys       Date:  2013-07       Impact factor: 4.071

8.  Irinotecan delivery by microbubble-assisted ultrasound: in vitro validation and a pilot preclinical study.

Authors:  J-M Escoffre; A Novell; S Serrière; T Lecomte; A Bouakaz
Journal:  Mol Pharm       Date:  2013-05-28       Impact factor: 4.939

9.  Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft.

Authors:  Spiros Kotopoulis; Anthony Delalande; Mihaela Popa; Veronika Mamaeva; Georg Dimcevski; Odd Helge Gilja; Michiel Postema; Bjørn Tore Gjertsen; Emmet McCormack
Journal:  Mol Imaging Biol       Date:  2014-02       Impact factor: 3.488

10.  First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound.

Authors:  Agessandro Abrahao; Ying Meng; Maheleth Llinas; Yuexi Huang; Clement Hamani; Todd Mainprize; Isabelle Aubert; Chinthaka Heyn; Sandra E Black; Kullervo Hynynen; Nir Lipsman; Lorne Zinman
Journal:  Nat Commun       Date:  2019-09-26       Impact factor: 14.919

View more
  2 in total

1.  An Affordable and Easy-to-Use Focused Ultrasound Device for Noninvasive and High Precision Drug Delivery to the Mouse Brain.

Authors:  Zhongtao Hu; Si Chen; Yaoheng Yang; Yan Gong; Hong Chen
Journal:  IEEE Trans Biomed Eng       Date:  2022-08-19       Impact factor: 4.756

Review 2.  HIF-1α Is a Rational Target for Future Ovarian Cancer Therapies.

Authors:  Xin Wang; Zhen-Wu Du; Tian-Min Xu; Xiao-Jun Wang; Wei Li; Jia-Li Gao; Jing Li; He Zhu
Journal:  Front Oncol       Date:  2021-12-24       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.